HW
ARIA

Hancock Whitney’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Hancock Whitney’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-40,000
Closed -$275K – 564
2014
Q4 		$275K Hold
40,000
– – 0.01% 469
2014
Q3 		$216K Hold
40,000
– – 0.01% 470
2014
Q2 		$255K Hold
40,000
– – 0.01% 466
2014
Q1 		$322K Buy
+40,000
New +$312K 0.01% 458

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hancock Whitney's ARIA Position: Q1 2015 in Review

Hancock Whitney sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2015, closing a stake of 40,000 shares — an estimated $275K sold.

Hancock Whitney first reported a position in ARIA in Q1 2014 and held it in 4 quarters. The position peaked at $322K in Q1 2014. 193 funds tracked by Wall St. Rank hold ARIA as of Q1 2015.

  • Hancock Whitney reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Hancock Whitney sold 40,000 Ariad Pharmaceuticals Inc shares in Q1 2015, an estimated $275K.
  • Hancock Whitney first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 4 quarters.
  • Hancock Whitney's Ariad Pharmaceuticals Inc position peaked at $322K in Q1 2014.
  • 193 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2015.

Based on Hancock Whitney's 13F filing for Q1 2015, filed 14 May 2015.